Comparative Overall Comorbidity Burden Among Patients With Hidradenitis Suppurativa

Acne

Incidence of Long-term Opioid Use Among Opioid-Naive Patients With Hidradenitis Suppurativa in the United States

JAMA Dermatol.

Reddy S, Orenstein LAV, Strunk A, Garg A

doi: 10.1001/jamadermatol.2019.2610.

Acne

Assessment of Overall and Specific Cancer Risks in Patients With Hidradenitis Suppurativa

JAMA Dermatol.

Jung JM, Lee KH, Kim YJ, Chang SE, Lee MW, Choi JH, Won CH, Lee WJ

doi: 10.1001/jamadermatol.2020.1422.

AcneAtopic DermatitisPsoriasis

Comparing the Effectiveness and Safety Associated With Infliximab vs Infliximab-abda Therapy for Patients With Hidradenitis Suppurativa

JAMA Dermatol

Westerkam LL, Tackett KJ, Sayed CJ

doi: 10.1001/jamadermatol.2021.0220

AcnePsoriasis

Hidradenitis Suppurativa Among Patients with Human Immunodeficiency Virus: Investigating Patient and Disease Characteristics, and Misdiagnosis

Br J Dermatol

Bui H, Skiba PN, Breskin A, Sayed C

doi: 10.1111/bjd.20591

Acne

Hidradenitis Suppurativa Odor and Drainage Scale: A Novel Method for Evaluating Odor and Drainage in Patients with Hidradenitis Suppurativa

Br J Dermatol

Machado MO, Lu JD, Brar R, Kirby J, Garg A, Lowes M, Piguet V, Alavi A

doi: 10.1111/bjd.19686

Acne

High prevalence of non-alcoholic fatty liver disease among hidradenitis suppurativa patients independent of classic metabolic risk factors

J Eur Acad Dermatol Venereol.

Durán-Vian C, Arias-Loste MT, Hernández JL, Fernández V, González M, Iruzubieta P, Rasines L, González-Vela C, Vaqué JP, Blanco R, Crespo J, González-López MA

doi: 10.1111/jdv.15764.

Acne

Incidence of Myocardial Infarction and Cerebrovascular Accident in Patients With Hidradenitis Suppurativa

JAMA Dermatol.

Reddy S, Strunk A, Jemec GBE, Garg A

doi: 10.1001/jamadermatol.2019.3412.

The Follicular Skin Microbiome in Patients With Hidradenitis Suppurativa and Healthy Controls

JAMA Dermatol.

Ring HC, Thorsen J, Saunte DM, Lilje B, Bay L, Riis PT, Larsen N, Andersen LO, Nielsen HV, Miller IM, Bjarnsholt T, Fuursted K, Jemec GB

doi: 10.1001/

COMMENTED

Acne

North American Clinical Management Guidelines for Hidradenitis Suppurativa: a Publication from the United States and Canadian Hidradenitis Suppurativa Foundations. Part I: Diagnosis, Evaluation, and the use of Complementary and Procedural Management

J Am Acad Dermatol.

Alikhan A, Sayed C, Alavi A, Alhusayen R, Brasasard A, Burkhart C, Crowell K, Eisen D, Gottlieb A, Hamzavi I, Hazen P, Jaleel T, Kimball A, Kirby J, Lowes MA, Micheletti R, Miller A, Naik HB, Orgill D, Poulin Y

doi: 10.1016/j.jaad.2019.02.067.

Related content

Incidence of Long-term Opioid Use Among Opioid-Naive Patients With Hidradenitis Suppurativa in the United States

Assessment of Overall and Specific Cancer Risks in Patients With Hidradenitis Suppurativa

Comparing the Effectiveness and Safety Associated With Infliximab vs Infliximab-abda Therapy for Patients With Hidradenitis Suppurativa

Hidradenitis Suppurativa Among Patients with Human Immunodeficiency Virus: Investigating Patient and Disease Characteristics, and Misdiagnosis

Hidradenitis Suppurativa Odor and Drainage Scale: A Novel Method for Evaluating Odor and Drainage in Patients with Hidradenitis Suppurativa

High prevalence of non-alcoholic fatty liver disease among hidradenitis suppurativa patients independent of classic metabolic risk factors

Incidence of Myocardial Infarction and Cerebrovascular Accident in Patients With Hidradenitis Suppurativa

The Follicular Skin Microbiome in Patients With Hidradenitis Suppurativa and Healthy Controls

North American Clinical Management Guidelines for Hidradenitis Suppurativa: a Publication from the United States and Canadian Hidradenitis Suppurativa Foundations. Part I: Diagnosis, Evaluation, and the use of Complementary and Procedural Management